<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107459</article-id><article-id pub-id-type="doi">10.7554/eLife.107459</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Neurodevelopmental Disorders</subject></subj-group></article-categories><title-group><article-title>Unraveling the impact of genetic variants</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Herring</surname><given-names>Bruce</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6974-5911</contrib-id><email>bherring@usc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Bruce Herring</bold> is in the Department of Biological Sciences, University of Southern California, Los Angeles, United States</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03taz7m60</institution-id><institution>Department of Biological Sciences, University of Southern California</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>09</day><month>06</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e107459</elocation-id><permissions><copyright-statement>© 2025, Herring</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Herring</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107459-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.103620" id="ra1"/><abstract><p>Experiments in mice reveal how three rare mutations in a gene called <italic>TRIO</italic> can lead to different neurodevelopmental outcomes.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>TRIO</kwd><kwd>neurodevelopment disorders</kwd><kwd>Rac1</kwd><kwd>presynaptic</kwd><kwd>RhoA</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Experiments in mice reveal how three rare mutations in a gene called <italic>TRIO</italic> can lead to different neurodevelopmental outcomes.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Ishchenko Y, Jeng AT, Feng S, Nottoli T, Manriquez-Rodriguez C, Nguyen KK, Carrizales MG, Vitarelli MJ, Corcoran EE, Greer CA, Myers SA, Koleske AJ. 2025. Heterozygosity for neurodevelopmental disorder-associated <italic>TRIO</italic> variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice. <italic>eLife</italic> <bold>13</bold>:RP103620. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.103620">10.7554/eLife.103620</ext-link>.</p></boxed-text><p>Neurodevelopmental disorders like autism spectrum disorder, schizophrenia, and bipolar disorder are deeply complex conditions, with each involving a mosaic of genetic and environmental contributors. A number of risk genes have been identified, but pinpointing how a particular mutation in one of these genes translates into specific neuronal and behavioral phenotypes remains a challenge.</p><p>One risk gene, known as <italic>TRIO</italic>, encodes a large signaling protein that contains two guanine nucleotide exchange factor (GEF) domains. One of these domains activates an enzyme called Rac1, while the other activates an enzyme called RhoA (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These enzymes have important roles in brain development as they are involved in regulating the development of neurons, dendrites and synapses (<xref ref-type="bibr" rid="bib5">Paskus et al., 2020</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Phenotypes observed in mouse models of <italic>TRIO</italic> dysfunction.</title><p>The GEF1 and GEF2 domains of the TRIO protein (top) activate enzymes called Rac 1 and RhoA, respectively. Ishchenko et al. generated three mouse strains (middle), each with a distinct mutation in the <italic>Trio</italic> gene that was associated with a specific neurodevelopmental/psychiatric disorder. The mutations were introduced in only one copy of the gene in order to mimic the genetic structure of humans with these <italic>TRIO</italic>-associated brain disorders. The K1431M mutation (green; left), which is associated with autism spectrum disorder, increased the activity and expression of certain proteins, while reducing the probability of glutamate release, and also reducing interactions with other mice. The K1918X mutation (orange; center), which is associated with schizophrenia, had an adverse impact on the expression of Trio, cortical thickness and memory-associated tasks. The M2145T mutation (blue; right), which is associated with bipolar disorder, reduced the activity of some proteins while increasing the expression of others, and also reduced the probability of glutamate release. GEF: guanine nucleotide exchange factor.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107459-fig1-v1.tif"/></fig><p>Importantly, different mutations in <italic>TRIO</italic> have been strongly linked to distinct neurodevelopmental disorders (<xref ref-type="bibr" rid="bib5">Paskus et al., 2020</xref>; <xref ref-type="bibr" rid="bib7">Singh et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Genovese et al., 2016</xref>; <xref ref-type="bibr" rid="bib4">Katrancha et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Sadybekov et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Barbosa et al., 2020</xref>). This makes <italic>Trio</italic> an exceptional model for studying how precise molecular alterations can drive varied disease phenotypes. Now, in eLife, Anthony Koleske and colleagues from Yale University, the La Jolla Institute for Immunology and the Chinese PLA General Hospital – including Yevheniia Ishchenko as first author – report the distinct effects of three different <italic>Trio</italic> mutations on brain development and behavior in mice (<xref ref-type="bibr" rid="bib3">Ishchenko et al., 2025</xref>).</p><p>Ishchenko et al. began by engineering mice to carry one of three rare <italic>TRIO</italic> mutations: K1431M (autism spectrum disorder), K1918X (schizophrenia), and M2145T (bipolar disorder). Each mutation was present in a single copy of the gene to reflect the heterozygous nature of the human genetics, where one mutated copy is paired with a normal copy of the gene. The team then conducted a comprehensive battery of behavioral, anatomical, electrophysiological, and biochemical analyses.</p><p>The analyses revealed that each variant produced unique phenotypic profiles in mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>). K1431M mice showed a reduced probability of releasing the neurotransmitter glutamate (indicating impaired synapse function) and robust social deficits, such as decreased time spent interacting with other mice. K1918X mutants exhibited a thinner brain cortex, reduced dendrite complexity, and impaired ability to tell novel objects from familiar objects, suggesting an impact on specific types of memory. In M2145T mice, while behavioral impacts were more subtle, there were clear synaptic transmission defects including increased glutamate release probability. Together, these findings underscore how individual mutations in the same gene can selectively perturb different aspects of brain function.</p><p>One particularly intriguing discovery came from the K1431M variant. Although this mutation reduces the ability of the Trio protein to activate Rac1, mutant mice instead showed elevated Rac1 activity in the cortex. This might be explained by increased expression of Tiam1, another protein that can activate Rac1, suggesting a compensatory response that may itself contribute to dysfunction. Pharmacological inhibition of Rac1 partially restored synaptic function in these mice, hinting at possible therapeutic avenues.</p><p>Unlike some previous studies that relied on fully knocking out or overexpressing genes, the work of Ishchenko et al. models the subtler heterozygous mutations found in individuals. The findings demonstrate that such single-copy changes are sufficient to disrupt neuronal development and behavior in mutation-specific ways.</p><p>Future studies using these rodent models should examine how such mutations alter neuronal activity patterns in mice, and how different environmental factors impact their effects. Complementary modeling in human-derived neurons may also help identify the changes that are translationally relevant, and could reveal whether other components of the Trio signaling pathway could serve as biomarkers of neurodevelopmental disorders or therapeutic targets.</p><p>More broadly, this study emphasizes the power of variant-specific modeling to decode the molecular underpinnings of neurodevelopmental and psychiatric disease. As genetic sequencing becomes increasingly integrated into clinical care, understanding the functional consequences of individual variants will be critical for translating genomic information into actionable insight.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>S</given-names></name><name><surname>Greville-Heygate</surname><given-names>S</given-names></name><name><surname>Bonnet</surname><given-names>M</given-names></name><name><surname>Godwin</surname><given-names>A</given-names></name><name><surname>Fagotto-Kaufmann</surname><given-names>C</given-names></name><name><surname>Kajava</surname><given-names>AV</given-names></name><name><surname>Laouteouet</surname><given-names>D</given-names></name><name><surname>Mawby</surname><given-names>R</given-names></name><name><surname>Wai</surname><given-names>HA</given-names></name><name><surname>Dingemans</surname><given-names>AJM</given-names></name><name><surname>Hehir-Kwa</surname><given-names>J</given-names></name><name><surname>Willems</surname><given-names>M</given-names></name><name><surname>Capri</surname><given-names>Y</given-names></name><name><surname>Mehta</surname><given-names>SG</given-names></name><name><surname>Cox</surname><given-names>H</given-names></name><name><surname>Goudie</surname><given-names>D</given-names></name><name><surname>Vansenne</surname><given-names>F</given-names></name><name><surname>Turnpenny</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>M</given-names></name><name><surname>Cogné</surname><given-names>B</given-names></name><name><surname>Lesca</surname><given-names>G</given-names></name><name><surname>Hertecant</surname><given-names>J</given-names></name><name><surname>Rodriguez</surname><given-names>D</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Burglen</surname><given-names>L</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Putoux</surname><given-names>A</given-names></name><name><surname>Cantagrel</surname><given-names>V</given-names></name><name><surname>Siquier-Pernet</surname><given-names>K</given-names></name><name><surname>Rio</surname><given-names>M</given-names></name><name><surname>Banka</surname><given-names>S</given-names></name><name><surname>Sarkar</surname><given-names>A</given-names></name><name><surname>Steeves</surname><given-names>M</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Clement</surname><given-names>E</given-names></name><name><surname>Moutton</surname><given-names>S</given-names></name><name><surname>Tran Mau-Them</surname><given-names>F</given-names></name><name><surname>Piton</surname><given-names>A</given-names></name><name><surname>de Vries</surname><given-names>BBA</given-names></name><name><surname>Guille</surname><given-names>M</given-names></name><name><surname>Debant</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Baralle</surname><given-names>D</given-names></name><collab>C4RCD Research Group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Opposite modulation of RAC1 by mutations in TRIO is associated with distinct, domain-specific neurodevelopmental disorders</article-title><source>American Journal of Human Genetics</source><volume>106</volume><fpage>338</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2020.01.018</pub-id><pub-id pub-id-type="pmid">32109419</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Ruderfer</surname><given-names>DM</given-names></name><name><surname>Chambert</surname><given-names>K</given-names></name><name><surname>Landén</surname><given-names>M</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>1433</fpage><lpage>1441</lpage><pub-id pub-id-type="doi">10.1038/nn.4402</pub-id><pub-id pub-id-type="pmid">27694994</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishchenko</surname><given-names>Y</given-names></name><name><surname>Jeng</surname><given-names>AT</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Nottoli</surname><given-names>T</given-names></name><name><surname>Manriquez-Rodriguez</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>KK</given-names></name><name><surname>Carrizales</surname><given-names>MG</given-names></name><name><surname>Vitarelli</surname><given-names>MJ</given-names></name><name><surname>Corcoran</surname><given-names>EE</given-names></name><name><surname>Greer</surname><given-names>CA</given-names></name><name><surname>Myers</surname><given-names>SA</given-names></name><name><surname>Koleske</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Heterozygosity for neurodevelopmental disorder-associated <italic>TRIO</italic> variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice</article-title><source>eLife</source><volume>13</volume><elocation-id>RP103620</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.103620</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katrancha</surname><given-names>SM</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><name><surname>Koleske</surname><given-names>AJ</given-names></name><name><surname>Mains</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neurodevelopmental disease-associated de novo mutations and rare sequence variants affect TRIO GDP/GTP exchange factor activity</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>4728</fpage><lpage>4740</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx355</pub-id><pub-id pub-id-type="pmid">28973398</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paskus</surname><given-names>JD</given-names></name><name><surname>Herring</surname><given-names>BE</given-names></name><name><surname>Roche</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Kalirin and Trio: RhoGEFs in synaptic transmission, plasticity, and complex brain disorders</article-title><source>Trends in Neurosciences</source><volume>43</volume><fpage>505</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2020.05.002</pub-id><pub-id pub-id-type="pmid">32513570</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadybekov</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Arnesano</surname><given-names>C</given-names></name><name><surname>Katritch</surname><given-names>V</given-names></name><name><surname>Herring</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>601</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00472-0</pub-id><pub-id pub-id-type="pmid">28928363</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>T</given-names></name><name><surname>Poterba</surname><given-names>T</given-names></name><name><surname>Curtis</surname><given-names>D</given-names></name><name><surname>Akil</surname><given-names>H</given-names></name><name><surname>Al Eissa</surname><given-names>M</given-names></name><name><surname>Barchas</surname><given-names>JD</given-names></name><name><surname>Bass</surname><given-names>N</given-names></name><name><surname>Bigdeli</surname><given-names>TB</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Bromet</surname><given-names>EJ</given-names></name><name><surname>Buckley</surname><given-names>PF</given-names></name><name><surname>Bunney</surname><given-names>WE</given-names></name><name><surname>Bybjerg-Grauholm</surname><given-names>J</given-names></name><name><surname>Byerley</surname><given-names>WF</given-names></name><name><surname>Chapman</surname><given-names>SB</given-names></name><name><surname>Chen</surname><given-names>WJ</given-names></name><name><surname>Churchhouse</surname><given-names>C</given-names></name><name><surname>Craddock</surname><given-names>N</given-names></name><name><surname>Cusick</surname><given-names>CM</given-names></name><name><surname>DeLisi</surname><given-names>L</given-names></name><name><surname>Dodge</surname><given-names>S</given-names></name><name><surname>Escamilla</surname><given-names>MA</given-names></name><name><surname>Eskelinen</surname><given-names>S</given-names></name><name><surname>Fanous</surname><given-names>AH</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Fiorentino</surname><given-names>A</given-names></name><name><surname>Francioli</surname><given-names>L</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gage</surname><given-names>D</given-names></name><name><surname>Gagliano Taliun</surname><given-names>SA</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Glahn</surname><given-names>DC</given-names></name><name><surname>Grove</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>M-H</given-names></name><name><surname>Hämäläinen</surname><given-names>E</given-names></name><name><surname>Heyne</surname><given-names>HO</given-names></name><name><surname>Holi</surname><given-names>M</given-names></name><name><surname>Hougaard</surname><given-names>DM</given-names></name><name><surname>Howrigan</surname><given-names>DP</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Hwu</surname><given-names>H-G</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Knowles</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name><name><surname>Lehrer</surname><given-names>DS</given-names></name><name><surname>Lescai</surname><given-names>F</given-names></name><name><surname>Malaspina</surname><given-names>D</given-names></name><name><surname>Marder</surname><given-names>SR</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>McIntosh</surname><given-names>AM</given-names></name><name><surname>Medeiros</surname><given-names>H</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Morley</surname><given-names>CP</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>O’Brien</surname><given-names>NL</given-names></name><name><surname>Olivares</surname><given-names>AM</given-names></name><name><surname>Ongur</surname><given-names>D</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Palmer</surname><given-names>DS</given-names></name><name><surname>Paunio</surname><given-names>T</given-names></name><name><surname>Quested</surname><given-names>D</given-names></name><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Rees</surname><given-names>E</given-names></name><name><surname>Rollins</surname><given-names>B</given-names></name><name><surname>Satterstrom</surname><given-names>FK</given-names></name><name><surname>Schatzberg</surname><given-names>A</given-names></name><name><surname>Scolnick</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Sharp</surname><given-names>SI</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Sobell</surname><given-names>JL</given-names></name><name><surname>Solomonson</surname><given-names>M</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Stevens</surname><given-names>CR</given-names></name><name><surname>Suvisaari</surname><given-names>J</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Watson</surname><given-names>SJ</given-names></name><name><surname>Watts</surname><given-names>NA</given-names></name><name><surname>Blackwood</surname><given-names>DH</given-names></name><name><surname>Børglum</surname><given-names>AD</given-names></name><name><surname>Cohen</surname><given-names>BM</given-names></name><name><surname>Corvin</surname><given-names>AP</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Freimer</surname><given-names>NB</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Pato</surname><given-names>CN</given-names></name><name><surname>Pato</surname><given-names>MT</given-names></name><name><surname>Pulver</surname><given-names>AE</given-names></name><name><surname>St Clair</surname><given-names>D</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name><name><surname>Vawter</surname><given-names>MP</given-names></name><name><surname>Walters</surname><given-names>JT</given-names></name><name><surname>Werge</surname><given-names>TM</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Rare coding variants in ten genes confer substantial risk for schizophrenia</article-title><source>Nature</source><volume>604</volume><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04556-w</pub-id><pub-id pub-id-type="pmid">35396579</pub-id></element-citation></ref></ref-list></back></article>